The cost of Spravato (esketamine) nasal spray varies depending on factors such as insurance coverage, pharmacy, and the specific dosage administered. For patients with commercial insurance, out-of-pocket costs can range from $10 to $35 per dose with the Janssen CarePath Savings Program [1]. Without insurance, the cost can be significantly higher, potentially reaching hundreds of dollars per dose [2].
What factors influence Spravato's price?
The price of Spravato is influenced by several components, including the manufacturing costs, research and development expenses, and the value it brings to patients in treating serious mental health conditions [3]. Additionally, the specialized administration requirements for Spravato, which necessitate monitoring in a certified healthcare setting for at least two hours after administration, contribute to the overall cost of treatment [4].
How does insurance coverage affect Spravato's out-of-pocket cost?
Insurance plans have different formularies and coverage levels for medications. While many commercial insurance plans cover Spravato, the exact co-pay or co-insurance amount a patient is responsible for will depend on their specific plan benefits [1]. Patients with Medicare or Medicaid may have different coverage options, and the Janssen CarePath program also offers resources for these individuals [1].
Are there patient assistance programs for Spravato?
Yes, Janssen Pharmaceuticals, the manufacturer of Spravato, offers the Janssen CarePath program, which provides financial assistance and support services to eligible patients. This program includes a Savings Program for commercially insured patients that can significantly reduce out-of-pocket costs per dose [1].
How is Spravato administered and what does that add to the cost?
Spravato is administered as a nasal spray in a certified healthcare setting. After administration, patients must be monitored for at least two hours to observe for adverse reactions, such as sedation and dissociation. This required monitoring period, along with the professional administration, is part of the overall treatment protocol and contributes to the total cost of care [4].
What is the typical dosage of Spravato and how does it impact cost?
The typical starting dosage for Spravato is 56 mg on the first day of treatment, followed by 56 mg or 112 mg for subsequent treatments [5]. Dosage adjustments may be made by a healthcare provider based on patient response and tolerability. Higher or more frequent dosages would naturally result in higher overall treatment costs.
Where can I find more information on Spravato costs and savings?
For detailed information on Spravato costs, insurance coverage, and available savings programs, patients can consult the official Spravato website or the Janssen CarePath program website. DrugPatentWatch.com also tracks patent and exclusivity information for various drugs, which can indirectly influence long-term pricing trends [6].
*
**Sources:
1. Janssen CarePath Savings Program. https://www.janssencarepath.com/spravato
2. GoodRx. (n.d.). Esketamine Nasal Pricing. https://www.goodrx.com/esketamine-nasal
3. FDA. (2020). Spravato (esketamine) nasal spray. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210834s011lbl.pdf
4. Spravato Official Website. (n.d.). About Spravato. https://www.spravato.com/about-spravato
5. Spravato Official Website. (n.d.). Dosing Information. https://www.spravato.com/dosing-information
6. DrugPatentWatch.com. (n.d.). https://drugpatentwatch.com/